Electroporation-Facilitated Delivery of Plasmid DNA in Skeletal Muscle: Plasmid Dependence of Muscle Damage and Effect of Poloxamer 188-Reference-Cited by-同舟云学术

Electroporation-Facilitated Delivery of Plasmid DNA in Skeletal Muscle: Plasmid Dependence of Muscle Damage and Effect of Poloxamer 188

Published:2001-11 Issue:5 Volume:4 Page:407-415
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hartikka Jukka,Sukhu Loretta,Buchner Carol,Hazard Diane,Bozoukova Vesselina,Margalith Michal,Nishioka Walter K.,Wheeler Carl J.,Manthorp Marston,Sawdey Michael

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Direct gene transfer into mouse muscle in vivo;Wolff;Science,1990

2. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle;Davis;Hum. Gene Ther,1993

3. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy;Yang;Proc. Natl. Acad. Sci. USA,1994

4. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates;Parker;Hum. Gene Ther,1995

5. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α;Horton;Proc. Natl. Acad. Sci. USA,1999

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies;Pharmaceutics;2024-04-17

2. Efficacy and advantage of immunotherapy for melanoma via intramuscular co-expression of plasmid-encoded PD-1 and CTLA-4 scFvs;American Journal of Cancer Research;2024

3. In situ transient transfection of 3D cell cultures and tissues, a promising tool for tissue engineering and gene therapy;Biotechnology Advances;2023-11

4. A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19;Molecular Therapy;2023-03

5. Nanotechnology for DNA and RNA delivery;Nanomedicine;2023